Fundraising Fox
🦊/Companies
Sign in

Curesponse

2 known investors

Find your way into Curesponse

328 people in our graph share verified history with the Curesponse team — schools, employers, funds. One of them is your warm intro.

Rochelle Ramunlockedknows Guy Neev · together at Bar-Ilan University (overlapped)
×8knows the team · via Norwegian School of Economics (NHH)
×3knows the team · via Bar-Ilan University

Curesponse applies science and technology to improve cancer treatment, bringing together medical executives, scientists, and clinical and regulatory experts. The company operates laboratories in the UK and Israel to support oncology treatment decisions.

AI & Machine LearningBiotechDigital HealthHealthtech

Founders & leadership

GNGuy Neev
Guy NeevinCo-Founder & CEOCo-founder and CEO of Curesponse, which applies science and technology to support oncology treatment decisions through laboratories in the UK and Israel.
DRDr. Ravid Straussman
Dr. Ravid StraussmanScientific Founder
DSDr. Seth Salpeter
Dr. Seth SalpeterCo-Founder & CTO
EDEran Dor
Eran DorCFO

Investors · 2

NCL Technology Ventures Ltd.London
aMoonreported · 2 sourcesRa'anana

Funding

SEC filings, press & company announcements

$6M disclosed across 1 of 3 rounds · 2020–2021

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Team - Curesponse | Better Cancer Carecuresponse.com · Dec 2022Curesponse Secures Additional USD 8 Million Funding for Its Breakthrough Precision Oncology Platformglobenewswire.com · Nov 2021Curesponse - Raised $6 Million From Investors Including NCL Technology Ventures, Amoon | Reutersreuters.com · Jun 2020Curesponse Secures $6M Series A for Breakthrough Precision Medicineprnewswire.com · Jun 2020Israeli Startup Curesponse Raises $6M in Series A Financing | Precision Medicine Onlineprecisionmedicineonline.com · Jun 2020

Frequently asked questions

What does Curesponse do?
Curesponse applies science and technology to improve cancer treatment, bringing together medical executives, scientists, and clinical and regulatory experts. The company operates laboratories in the UK and Israel to support oncology treatment decisions.
Who founded Curesponse?
Curesponse was founded by Guy Neev, Dr. Ravid Straussman, Dr. Seth Salpeter.
Who are Curesponse's investors?
Curesponse's investors include NCL Technology Ventures Ltd., aMoon.
How much funding has Curesponse raised?
Curesponse has disclosed $6M raised across 1 of its 3 known rounds.